Kim Margolin
SWOG Cancer Research Network
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Wenyin Shi, MD, PhD
Thomas Jefferson University
Shared therapeutic areas:
Evanthia Galanis
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey Weber
University of Southern California
Shared therapeutic areas:
Worked with same sponsors:
Cassian Yee
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
David Solit
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Kevin Kim
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Paul Chapman
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Robert Vonderheide, MD, DPhil
Abramson Cancer Center at Penn Medicine
Shared therapeutic areas:
Frank Hodi
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Thomas Gajewski
University of Chicago Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
All 2 trials loaded